In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

General Surgical Innovations forms cardiovascular distribution deals:

This article was originally published in Clinica

Executive Summary

General Surgical Innovations has signed exclusive distribution agreements for its range of cardiovascular products in the UK, Germany, Belgium, Holland, Italy, Portugal, Spain. The agreements with unnamed distributors include its Endosaph system for the minimally-invasive harvesting of the saphenous vein and the surgical balloon dissector for subfascial endoscopic perforator surgery. The company has a direct sales force in the US and sells in Japan through an exclusive distribution agreement.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080566

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel